Eleni Tousimis
Biographic Data
| ID | 5533859 |
|---|---|
| NAME | Eleni Tousimis |
| GIVEN NAMES | Eleni |
| FAMILY NAME | Tousimis |
| SIGNATURE | TOUSIMIS E |
| AFFILIATIONS | MedStar Georgetown University Hospital, Washington, DC, USA |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven
A new breast cancer treatment, brachytherapy-based accelerated partial breast radiotherapy (RT), was adopted before long-term effectiveness evidence, potentially increasing morbidity and costs compared with whole breast RT. The aim of this study was to estimate complication rates and RT-specific and 1-year costs for a cohort of female Medicare beneficiaries diagnosed with breast cancer (N = 47 969). We analyzed 2005-2007 Medicare claims using mul…
Diffusion of Accelerated Partial Breast Radiotherapy in the United States
PURPOSE: To evaluate diffusion of brachytherapy-based accelerated partial breast radiotherapy (RT) in the United States, a new breast cancer treatment requiring 5 days twice daily, rather than daily treatment for 6-7 weeks. It has limited long-term effectiveness data compared with standard whole breast RT. DATA AND METHODS: We used 2005-2008 Medicare claims for female Medicare beneficiaries receiving RT after breast-conserving surgery merged with…
No prominent works on this page.
Diffusion of Accelerated Partial Breast Radiotherapy in the United States
PURPOSE: To evaluate diffusion of brachytherapy-based accelerated partial breast radiotherapy (RT) in the United States, a new breast cancer treatment requiring 5 days twice daily, rather than daily treatment for 6-7 weeks. It has limited long-term effectiveness data compared with standard whole breast RT. DATA AND METHODS: We used 2005-2008 Medicare claims for female Medicare beneficiaries receiving RT after breast-conserving surgery merged with…
New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven
A new breast cancer treatment, brachytherapy-based accelerated partial breast radiotherapy (RT), was adopted before long-term effectiveness evidence, potentially increasing morbidity and costs compared with whole breast RT. The aim of this study was to estimate complication rates and RT-specific and 1-year costs for a cohort of female Medicare beneficiaries diagnosed with breast cancer (N = 47 969). We analyzed 2005-2007 Medicare claims using mul…
Brachytherapy (2 works) · Breast cancer (2 works) · Breast Cancer Treatment Studies (2 works) · Cancer (2 works) · Confidence interval (2 works) · Global Cancer Incidence and Screening (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Logistic regression (2 works) · Medicine (2 works)